Vanda Pharmaceuticals Stock
Price
Target price
€4.36
€4.36
-2.080%
-0.094
-2.080%
€17.17
13.08.26 / Tradegate
WKN: A0JJT3 / Symbol: VNDA / Name: Vanda Pharma / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Vanda Pharmaceuticals Stock
We can see a decrease in the price for Vanda Pharmaceuticals. Compared to yesterday it has lost -€0.094 (-2.080%).
With 10 Buy predictions and not the single Sell prediction the community is currently very high on Vanda Pharmaceuticals.
With a target price of 17 € there is potential for a 289.91% increase which would mean more than doubling the current price of 4.36 € for Vanda Pharmaceuticals.
So far the community has only identified positive things for Vanda Pharmaceuticals stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Vanda Pharmaceuticals in the next few years
Pros
?
B****
?
S********** s********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Vanda Pharmaceuticals vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Vanda Pharmaceuticals | -2.080% | -1.802% | -20.293% | 21.111% | -29.677% | -17.736% | -68.857% |
| Heron Therapeutics Inc. | -4.020% | -32.607% | -20.601% | -75.641% | -73.914% | -80.497% | -96.899% |
| Evolus Inc | -0.060% | 27.435% | 22.133% | 31.811% | 28.183% | -21.506% | -21.506% |
| Rhythm Pharmaceuticals | 0.000% | 6.878% | 7.447% | 24.691% | 8.021% | 313.934% | 763.248% |
Comments
Vanda Pharmaceuticals (VNDA) had its "buy" rating reaffirmed by B. Riley Financial, Inc.. They now have a $12.00 price target on the stock, down from $17.00.
Show more
Ratings data for VNDA provided by MarketBeat
Vanda Pharmaceuticals (VNDA) had its "buy" rating reaffirmed by HC Wainwright.
Show more
Ratings data for VNDA provided by MarketBeat
Vanda Pharmaceuticals (VNDA) had its price target lowered by HC Wainwright from $24.00 to $21.00. They now have a "buy" rating on the stock.
Show more
Ratings data for VNDA provided by MarketBeat